U.S. FDA· @FDA · X·· 18 天前精选AI 评分50
AI 导读
FDA 宣布批准另外三款绝经期激素治疗(MHT)产品的标签更新,并表示正加快生产,让更多女性获得所需治疗。FDA 称此举是其女性健康承诺的一部分,直接支持总统特朗普于 2026 年 10 月 19 日签署的、聚焦各生命阶段女性健康结局的行政令。
推荐理由
FDA 为三款绝经期激素治疗产品更新标签,并说明与加快生产、行政令的关联,读者可了解美国监管层推动女性健康用药可及性的具体动作。
正文
FDA just approved updated labeling for three more menopause hormone therapy (MHT) products, additionally we are also working to speed up production so that more women can get the treatments they need. This is part of our commitment to women’s health and directly supports a recent Executive Order signed by President Trump on October 19, 2026, that focused on advancing health outcomes for women at every stage of life.
https://www.hhs.gov/press-room/fda-advances-menopause-care-hormone-therapy-labeling-access.html
来源:U.S. FDA · x.com